Skip to main content

News Archive

News Archive - School of Medicine

Study Identifies Previously Missed DNA Mutation Pattern in Colorectal Cancer

August 19, 2026

Researchers identified a previously overlooked pattern of DNA mutations in colorectal cancer. The pattern had been detected in large cancer-genome datasets before, but researchers had interpreted it as a combination of other, already known mutation patterns.

UC San Diego Receives $12.3 Million Grant to Study the Intersection of HIV and Methamphetamine Use

August 17, 2026

UC San Diego has launched Brain-FRAMe, an innovative program integrating neuroscience and immunology to improve brain health and clinical care for people living with HIV and methamphetamine use disorder.

Inside San Diego’s Innovation Engine

August 13, 2026

What powers San Diego’s innovation engine? When leading minds from academia, industry and government gathered at UC San Diego, the answer was clear: collaboration.

How Brain Ripples Keep Memory Online

August 12, 2026

Working memory is essential to our daily functioning, but there are still unanswered questions about how it works. UC San Diego researchers are helping answer them.

As New World Screwworm Returns to the U.S., UC San Diego and San Diego County Team Up to Track Risks

August 11, 2026

A new dashboard tracks New World screwworm risk levels county by county.

Scientists Uncover Cellular Mechanism Driving Both Rare Childhood Dementia and Alzheimer’s Disease

August 11, 2026

UC San Diego researchers have found a "genetic switch" triggering neurodegeneration in both a rare childhood dementia and Alzheimer's disease, pointing to new drug targets in the waste-processing system within the brain’s immune cells.

UC San Diego Named Central Lab for $101M XPRIZE Healthspan Competition

August 11, 2026

The Stein Institute for Research on Aging at UC San Diego will play a central role in an ambitious competition aimed at extending the human healthspan.

Rebecsinib Clinical Trial Means New Options for Blood Cancer

August 5, 2026

A clinical trial of rebecsinib — an investigational drug that inhibits the ADAR1 gene involved in the growth of more than 20 cancers — is underway at UC San Diego.

Mindfulness-Based Therapy for Opioid Misuse Offers Massive Return on Investment

August 5, 2026

A mindfulness-based treatment for opioid use disorder could generate $12 in economic benefit for every dollar spent, a massive improvement on current approaches.

One Month on a Vegan Diet Shifts Epigenetic Patterns Associated with Aging and Inflammation

August 4, 2026

Researchers from University of California San Diego have found that switching to a vegan diet for just one month can alter the body’s epigenetic landscape in ways associated with reduced inflammation and biological aging.
Category navigation with Social links